Johanna Kaufmann

Executive Vice President for Oncology at Codagenix Inc., USA

Speaker

Dr. Kaufmann is a scientific and strategic leader in immuno-oncology with broad expertise across preclinical and translational drug development. Before joining Codagenix, she was a Scientific Director at GSK, leading an immune biology group and supporting progression of multiple portfolio assets as part of the immuno-oncology senior leadership team. She previously led mechanisms of action studies for immuno-oncology assets at TESARO and headed three preclinical herpes virus vaccine programs at Genocea Biosciences. Dr. Kaufmann earned a MS in Molecular Medicine from Friedrich-Alexander University in Erlangen, Germany, and a PhD in Cancer Virology from the German Cancer Research Center (DKFZ) and Heidelberg University, Germany.